Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging.

Journal: NeuroImage
PMID:

Abstract

Specific brain structures (gray matter regions and white matter tracts) play a dominant role in determining cognitive decline and explain the heterogeneity in cognitive aging. Identification of these structures is crucial for screening of older adults at risk of cognitive decline. Using deep learning models augmented with a model-interpretation technique on data from 1432 Mayo Clinic Study of Aging participants, we identified a subset of brain structures that were most predictive of individualized cognitive trajectories and indicative of cognitively resilient vs. vulnerable individuals. Specifically, these structures explained why some participants were resilient to the deleterious effects of elevated brain amyloid and poor vascular health. Of these, medial temporal lobe and fornix, reflective of age and pathology-related degeneration, and corpus callosum, reflective of inter-hemispheric disconnection, accounted for 60% of the heterogeneity explained by the most predictive structures. Our results are valuable for identifying cognitively vulnerable individuals and for developing interventions for cognitive decline.

Authors

  • Krishnakant V Saboo
    University of Illinois, Dept. of Electrical and Computer Engineering, Urbana-Champaign, IL, USA. ksaboo2@illinois.edu.
  • Chang Hu
    Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Yogatheesan Varatharajah
    * Electrical and Computer Engineering, University of Illinois at Urbana-Champaign Urbana, IL 61801, USA.
  • Scott A Przybelski
    Mayo Clinic, Rochester MN, United States.
  • Robert I Reid
    Mayo Clinic, Rochester MN, United States.
  • Christopher G Schwarz
    Department of Radiology, Mayo Clinic and Foundation, Rochester, MN, USA.
  • Jonathan Graff-Radford
    Department of Neurology, Mayo Clinic and Foundation, Rochester, MN, USA.
  • David S Knopman
    Department of Neurology, Mayo Clinic and Foundation, Rochester, MN, USA.
  • Mary M Machulda
    Mayo Clinic, Rochester MN, United States.
  • Michelle M Mielke
    Division of Epidemiology, Department of Neurology, Mayo Clinic, Rochester, MN USA.
  • Ronald C Petersen
    Department of Neurology, Mayo Clinic, Rochester, USA.
  • Paul M Arnold
    1Carle Illinois College of Medicine, University of Illinois Urbana-Champaign, Champaign; and.
  • Gregory A Worrell
    Mayo Systems Electrophysiology Laboratory, Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • David T Jones
    Department of Computer Science, Bioinformatics Group, University College London, Gower Street, London, WC1E 6BT, United Kingdom. d.t.jones@ucl.ac.uk.
  • Clifford R Jack
    Department of Radiology, Mayo Clinic and Foundation, Rochester, MN, USA.
  • Ravishankar K Iyer
    Coordinated Science Laboratory, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
  • Prashanthi Vemuri
    Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.